Bladder cancer remains one of the most common cancers globally, with more than 600,000 new cases diagnosed annually. With limitations of the existing Transurethral Resection of Bladder Tumour (TURBT) treatment, recurrence rate of bladder cancers remains high (50%). Clinicians advocate for en bloc resection of early-stage bladder tumours, as this technique allows for the complete removal of the growth in one piece.